Cargando…
A ruthenium–oligonucleotide bioconjugated photosensitizing aptamer for cancer cell specific photodynamic therapy
Ruthenium complexes have emerged as a promising class of compounds for use as photosensitizers (PSs) in photodynamic therapy (PDT) due to their attractive photophysical properties and relative ease of chemical alteration. While promising, they generally are not inherently targeting to disease sites...
Autores principales: | McKenzie, Luke K., Flamme, Marie, Felder, Patrick S., Karges, Johannes, Bonhomme, Frederic, Gandioso, Albert, Malosse, Christian, Gasser, Gilles, Hollenstein, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8729177/ https://www.ncbi.nlm.nih.gov/pubmed/35128412 http://dx.doi.org/10.1039/d1cb00146a |
Ejemplares similares
-
Ruthenium-initiated polymerization of lactide: a route to remarkable cellular uptake for photodynamic therapy of cancer
por: Soliman, Nancy, et al.
Publicado: (2020) -
Applications of Ruthenium Complexes Covalently Linked to Nucleic Acid Derivatives
por: Flamme, Marie, et al.
Publicado: (2018) -
Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy
por: Karges, Johannes, et al.
Publicado: (2020) -
A mitochondria-localized iridium(iii) photosensitizer for two-photon photodynamic immunotherapy against melanoma
por: Wang, Lili, et al.
Publicado: (2023) -
Mitochondria
Targeted Protein-Ruthenium Photosensitizer
for Efficient Photodynamic Applications
por: Chakrabortty, Sabyasachi, et al.
Publicado: (2017)